Abstract
The results of this study suggest that exposure to styrene below the current Swedish permissible exposure limit of 20 ppm induces neurotoxic effects expressed as an increased number of neuropsychiatric symptoms. Twenty men exposed to styrene at a plastics factory participated. The reference group included 20 non-exposed men matched for age, working schedule, and physical work load. Exposure to styrene during one workday was assessed by personal air monitoring and biological monitoring. To evaluate the physical work load the pulse(heart) rate was measured. One week before the study each man completed a neuropsychiatric symptom questionnaire containing 16 items. Also 17 questions regarding acute symptoms of local irritation and symptoms of the central nervous system were presented after the psychometric tests were performed. The tests were simple reaction time, colour word vigilance, and symbol digit. A follow up with regard to the symptoms among the exposed men was done after their summer vacation, about two to five weeks after their last exposure. The mean eight hour time weighted average (TWA) concentration of styrene in air, measured by passive dosimetry was 8.6 ppm (range 0.04-50.4 ppm). The exposed men had significantly more symptoms than the referents although there were no significant differences for the psychometric tests. At the follow up the exposed men reported fewer symptoms. This study indicates that symptoms are earlier indicators of adverse effects than complex tests and underlines the importance of regular follow up of people exposed to styrene (and probably organic solvents in general).
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cherry N., Gautrin D. Neurotoxic effects of styrene: further evidence. Br J Ind Med. 1990 Jan;47(1):29–37. doi: 10.1136/oem.47.1.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Edling C., Ekberg K., Ahlborg G., Jr, Alexandersson R., Barregård L., Ekenvall L., Nilsson L., Svensson B. G. Long-term follow up of workers exposed to solvents. Br J Ind Med. 1990 Feb;47(2):75–82. doi: 10.1136/oem.47.2.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Edling C., Ekberg K. No acute behavioural effects of exposure to styrene: a safe level of exposure? Br J Ind Med. 1985 May;42(5):301–304. doi: 10.1136/oem.42.5.301. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Flodin U., Edling C., Axelson O. Clinical studies of psychoorganic syndromes among workers with exposure to solvents. Am J Ind Med. 1984;5(4):287–295. doi: 10.1002/ajim.4700050405. [DOI] [PubMed] [Google Scholar]
- Flodin U., Ekberg K., Andersson L. Neuropsychiatric effects of low exposure to styrene. Br J Ind Med. 1989 Nov;46(11):805–808. doi: 10.1136/oem.46.11.805. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hogstedt C., Hane M., Agrell A., Bodin L. Neuropsychological test results and symptoms among workers with well-defined long-term exposure to lead. Br J Ind Med. 1983 Feb;40(1):99–105. doi: 10.1136/oem.40.1.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Leibman K. C. Metabolism and toxicity of styrene. Environ Health Perspect. 1975 Jun;11:115–119. doi: 10.1289/ehp.7511115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ogata M., Taguchi T. Simultaneous determination of urinary creatinine and metabolites of toluene, xylene, styrene, ethylbenzene and phenol by automated high performance liquid chromatography. Int Arch Occup Environ Health. 1988;61(1-2):131–140. doi: 10.1007/BF00381617. [DOI] [PubMed] [Google Scholar]
- Tossavainen A. Styrene use and occupational exposure in the plastics industry. Scand J Work Environ Health. 1978;4 (Suppl 2):7–13. [PubMed] [Google Scholar]
- Triebig G., Lehrl S., Weltle D., Schaller K. H., Valentin H. Clinical and neurobehavioural study of the acute and chronic neurotoxicity of styrene. Br J Ind Med. 1989 Nov;46(11):799–804. doi: 10.1136/oem.46.11.799. [DOI] [PMC free article] [PubMed] [Google Scholar]